ICU Medical, Inc.

DB:IC7 Stock Report

Market Cap: €4.0b

ICU Medical Future Growth

Future criteria checks 3/6

ICU Medical is forecast to grow earnings and revenue by 72.6% and 1.1% per annum respectively. EPS is expected to grow by 72.2% per annum. Return on equity is forecast to be 6.8% in 3 years.

Key information

72.6%

Earnings growth rate

72.2%

EPS growth rate

Medical Equipment earnings growth14.2%
Revenue growth rate1.1%
Future return on equity6.8%
Analyst coverage

Good

Last updated14 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:IC7 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,463931882976
12/31/20252,398-51682637
12/31/20242,326-1121131347
9/30/20242,340-111160255N/A
6/30/20242,304-71157254N/A
3/31/20242,257-5975171N/A
12/31/20232,259-3073166N/A
9/30/20232,249-28-1373N/A
6/30/20232,294-48-4440N/A
3/31/20232,306-46-110-20N/A
12/31/20222,280-74-161-62N/A
9/30/20222,043-39-7822N/A
6/30/20221,7815-199N/A
3/31/20221,54141124215N/A
12/31/20211,316103186268N/A
9/30/20211,296109175263N/A
6/30/20211,279103168260N/A
3/31/20211,26094146235N/A
12/31/20201,27187122223N/A
9/30/20201,2668198193N/A
6/30/20201,2558373168N/A
3/31/20201,2648760162N/A
12/31/20191,266101-4102N/A
9/30/20191,291733103N/A
6/30/20191,311471104N/A
3/31/20191,3595557160N/A
12/31/20181,4002959160N/A
9/30/20181,4308690195N/A
6/30/20181,44686N/A242N/A
3/31/20181,41718N/A210N/A
12/31/20171,29369N/A154N/A
9/30/20171,01828N/A91N/A
6/30/201777247N/A19N/A
3/31/2017537101N/A-4N/A
12/31/201637963N/A90N/A
9/30/201637259N/A84N/A
6/30/201636156N/A77N/A
3/31/201634853N/A68N/A
12/31/201534045N/A64N/A
9/30/201532947N/A61N/A
6/30/201532137N/A61N/A
3/31/201531629N/A61N/A
12/31/201430726N/A66N/A
9/30/201430632N/A72N/A
6/30/201431137N/A69N/A
3/31/201431138N/A68N/A
12/31/201331240N/A66N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: IC7 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).

Earnings vs Market: IC7 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: IC7 is expected to become profitable in the next 3 years.

Revenue vs Market: IC7's revenue (1.1% per year) is forecast to grow slower than the German market (5.6% per year).

High Growth Revenue: IC7's revenue (1.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: IC7's Return on Equity is forecast to be low in 3 years time (6.8%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y